Skip to Main Content

Paper Details

Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial.
J Am Heart Assoc
3
2022
Author NameAffiliation
Christopher P CannonCardiovascular Division Brigham & Women's Hospital and Baim Institute for Clinical Research Boston MA.
Bernard ZinmanLunenfeld-Tanenbaum Research Institute, Mt Sinai Hospital University of Toronto Toronto ON.
Kenneth W MahaffeyStanford Center for Clinical Research, Department of Medicine Stanford University School of Medicine Stanford CA.
  • 1 - 3

Datasets